A surgical-robotics company whose Sentire system supports minimally invasive procedures with a multi-arm robot, surgeon console and integrated imaging.
M
Medtronic
Activity from announced rounds
All recorded activity
Medtronic is the healthcare-technology company identified as a strategic investor in Cornerstone and CereVasc announcements.
Recorded funding activity
Cornerstone develops surgical robots. CereVasc develops minimally invasive hydrocephalus treatment, while Pulnovo develops interventions for pulmonary hypertension and heart failure. These are distinct medical-device businesses within the recorded corporate activity.
- Rounds participated in
- 3
- Confirmed lead rounds
- 0 2 roles undisclosed
- New companies
- 3 First participation on record · 0 follow-on
- Funding in participating rounds
- $885M 3 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
3 in all activityCornerstone Robotics
$700MStrategic investment
ParticipantCereVasc
Develops minimally invasive eShunt System to treat communicating hydrocephalus and other neurological diseases
$85MSeries C
Role not disclosedPulnovo Medical
Develops interventional therapies for pulmonary hypertension and heart failure
$100MStrategic
Role not disclosed